Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cubist Touts Activity Of Its Broad-Spectrum Antibiotic Candidate Against High Value Gram-Negative Targets

Oct 01 2010

• By Pharmaceutical Approvals Monthly

Related Content

Antimicrobial Drug Approvals Should Include Pathogen-Specific Indications

Jul 23 2004

Chart: Fighting C. Difficile: Beyond Optimer's Fidaxomicin

Feb 01 2010

FDA's Pending HAP/VAP Guidance Could Further Dampen Antibiotic Drug Development

Oct 11 2010

Antibiotics Need "Societal Class" Designation To Improve Discovery, Discourage Use, Tufts Professor Tells Congress

Jul 26 2010

Cubist Hopes For A Blockbuster Antibiotic With In Acquisition Of Calixa

Dec 14 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window